News

The Pancreas, Biliary and Liver Surgery Center is under the leadership of Dr Michael Wayne, Dr Franklin Kassim and Dr Avram Cooperman. Under the terms of the agreement,

Menarini said that it is planning to launch other drugs shortly, notably in UK, Germany and Ireland. Thierry Poiraud, general manager of Menarini in France, said: “We are

Poniard said that the Phase 2 trial enrolled 32 men. The trial was designed to evaluate the efficacy and safety of intravenous Picoplatin (120mg/meter squared) administered every three

Atacama Labs Oy has developed an oral drug delivery technology (called ‘pneumatic dry granulation’ or ‘PDG Technology. The technology is aimed at replacing existing solid dosage form development

Reportedly, AuroSource is expected to partner with pharma firms globally and cultivate opportunities to research, manufacture and develop compounds across the entire drug life cycle. Aurobindo said that

The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin. The results

Hizentra, a once weekly immunoglobulin (Ig) replacement therapy, provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body. CSL Behring claimed

LIMS-on-Demand can reduce the capital investment associated with traditional LIMS implementation and validation by eliminating the need for extensive software testing and installation. On-demand access provides a more

OmniComm claimed that TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and